Literature DB >> 26577183

Determination of arylsulfatase A pseudodeficiency allele and haplotype frequency in the Tunisian population.

Nizar Ben Halim1, Imen Dorboz2,3, Rym Kefi4, Najla Kharrat5, Eleonore Eymard-Pierre6,7, Majdi Nagara4, Lilia Romdhane4, Nissaf Ben Alaya-Bouafif8, Ahmed Rebai5, Najoua Miladi2, Odile Boespflug-Tanguy3,9,10, Sonia Abdelhak4.   

Abstract

Arylsulfatase A (ASA) is a lysosomal enzyme involved in the catabolism of cerebroside sulfate. ASA deficiency is associated with metachromatic leukodystrophy (MLD). Low ASA activities have also been reported in a more common condition with no apparent clinical consequences termed ASA pseudo-deficiency (ASA-PD) which is associated with two linked mutations in the ASA gene (c.1049A>G and c.*96A>G). This study aimed to investigate the frequency of the two ASA-PD variants and their linkage disequilibrium (LD) among Tunisians. ASA-PD variants were detected in 129 healthy Tunisians and their frequencies were compared to those described worldwide. The frequency of the PD allele was estimated at 17.4% for the overall sample, with c.1049A>G and c.*96A>G frequencies of 25.6 and 17.4%, respectively. This study also revealed a high LD between the two ASA-PD variants (r(2) = 0.61). Inter-population analysis revealed similarities in the ASA-PD genetic structure between Tunisians and populations from Middle East with c.*96A>G frequencies being the highest in the world. A significant North vs. South genetic differentiation in the ASA-PD frequency was also observed in Tunisian population who seems genetically intermediate between Africans, Middle-Easterners and Europeans. This is the first report on the allele frequency of the ASA-PD in North Africa, revealing a relatively high frequency of the PD allele among Tunisians. This study gives also evidence on the importance of discriminating ASA-PD allele from pathological mutations causing MLD and supporting enzymatic activity testing with both sulfatiduria determination and genetic testing in the differential diagnosis of MLD in the Tunisian population.

Entities:  

Keywords:  Arylsulfatase A pseudo-deficiency; Genetic differentiation; Genetic polymorphism; Haplotype analysis; Linkage disequilibrium; Tunisia

Mesh:

Substances:

Year:  2015        PMID: 26577183     DOI: 10.1007/s10072-015-2417-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

2.  Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray ionization-tandem mass spectrometry.

Authors:  P D Whitfield; P C Sharp; D W Johnson; P Nelson; P J Meikle
Journal:  Mol Genet Metab       Date:  2001-05       Impact factor: 4.797

3.  The X chromosome Alu insertions as a tool for human population genetics: data from European and African human groups.

Authors:  Georgios Athanasiadis; Esther Esteban; Marc Via; Jean-Michel Dugoujon; Nicholas Moschonas; Hassen Chaabani; Pedro Moral
Journal:  Eur J Hum Genet       Date:  2007-02-28       Impact factor: 4.246

4.  Reduced activity of arylsulfatase A and predisposition to neurological disorders: analysis of 140 pediatric patients.

Authors:  S Sangiorgi; A Ferlini; A Zanetti; M Mochi
Journal:  Am J Med Genet       Date:  1991-09-01

5.  Evolutionary origins of two tightly linked mutations in arylsulfatase-A pseudodeficiency.

Authors:  R Ott; J S Waye; P L Chang
Journal:  Hum Genet       Date:  1997-12       Impact factor: 4.132

6.  Pseudodeficiency of arylsulphatase A: strategy for clarification of genotype in families of subjects with low ASA activity and neurological symptoms.

Authors:  S Leistner; E Young; C Meaney; B Winchester
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

7.  Arylsulphatase A pseudodeficiency in vascular dementia and Alzheimer's disease.

Authors:  M Philpot; K Lewis; M L Pereria; C Ward; C Holmes; S Lovestone; A Fensom; M Seller
Journal:  Neuroreport       Date:  1997-07-28       Impact factor: 1.837

8.  Arylsulfatase A pseudodeficiency: a common polymorphism which is associated with a unique haplotype.

Authors:  J Zlotogora; Y Furman-Shaharabani; S Goldenfum; B Winchester; K von Figura; V Gieselmann
Journal:  Am J Med Genet       Date:  1994-08-15

9.  Frequency of arylsulphatase A pseudodeficiency associated mutations in a healthy population.

Authors:  M L Barth; C Ward; A Harris; A Saad; A Fensom
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

10.  Arylsulfatase A pseudodeficiency and Lafora bodies in a patient with progressive myoclonic epilepsy.

Authors:  P Tinuper; G Plazzi; L Monari; S Sangiorgi; J F Pellissier; A Cerullo; F Provini; S Capellari; A Baruzzi; E Lugaresi
Journal:  Epilepsia       Date:  1994 Mar-Apr       Impact factor: 5.864

View more
  3 in total

Review 1.  Clinical and Genetic Characteristics of Leukodystrophies in Africa.

Authors:  Mutaz Amin; Liena Elsayed; Ammar Eltahir Ahmed
Journal:  J Neurosci Rural Pract       Date:  2017-08

2.  Arylsulfatase A pseudodeficiency in Mexico: Enzymatic activity and haplotype analysis.

Authors:  Jesús A Juárez-Osuna; Sandra C Mendoza-Ruvalcaba; Angela Porras-Dorantes; Thiago D Da Silva-José; José E García-Ortiz
Journal:  Mol Genet Genomic Med       Date:  2020-05-19       Impact factor: 2.183

3.  Enzyme activities of α-glucosidase in Japanese neonates with pseudodeficiency alleles.

Authors:  Ryuichi Mashima; Torayuki Okuyama
Journal:  Mol Genet Metab Rep       Date:  2017-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.